Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jarkko Rautio

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Molecules (Basel, Switzerland)|September 14, 2024
Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate DerivativesJelena Matović, Juulia Järvinen, Iris K Sokka, et al.
Journal of Medicinal Chemistry|January 26, 2008
Large neutral amino acid transporter enables brain drug delivery via prodrugsMikko Gynther, Krista Laine, Jarmo Ropponen, et al.
Bioorganic & Medicinal Chemistry|June 10, 2004
Synthesis and antileishmanial activity of novel buparvaquone oxime derivativesAntti Mäntylä, Jarkko Rautio, Tapio Nevalainen, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Protective Role and Enhanced Intracellular Uptake of Curcumin in Retinal Cells Using Self-Emulsifying Drug Delivery Systems (SNEDDS)Elide Zingale, Sebastiano Masuzzo, Tatu Lajunen, et al.
Pharmaceutical Research|October 19, 2013
Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamineLauri Peura, Kalle Malmioja, Kristiina Huttunen, et al.
Bioorganic Chemistry|May 2, 2021
Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocationJussi Kärkkäinen, Tuomo Laitinen, Magdalena Markowicz-Piasecka, et al.
Journal of Medicinal Chemistry|February 3, 2006
Evaluation of hydroxyimine as cytochrome P450-selective prodrug structureHanna Kumpulainen, Niina Mähönen, Marja-Leena Laitinen, et al.
Pharmaceutical Research|March 21, 2007
Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionalityKristiina M Huttunen, Niina Mähönen, Jukka Leppänen, et al.
International Journal of Pharmaceutics|April 19, 2018
Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptakeJussi Kärkkäinen, Mikko Gynther, Tarja Kokkola, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 6, 2025
Synthesis, in vitro characterization and biopharmaceutical evaluation of a novel phosphate prodrug of sorafenibSimon Hoang Dinh, Christian Ding Fisker, Juulia Järvinen, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Molecules (Basel, Switzerland)|September 14, 2024
Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate DerivativesJelena Matović, Juulia Järvinen, Iris K Sokka, et al.
Journal of Medicinal Chemistry|January 26, 2008
Large neutral amino acid transporter enables brain drug delivery via prodrugsMikko Gynther, Krista Laine, Jarmo Ropponen, et al.
Bioorganic & Medicinal Chemistry|June 10, 2004
Synthesis and antileishmanial activity of novel buparvaquone oxime derivativesAntti Mäntylä, Jarkko Rautio, Tapio Nevalainen, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Protective Role and Enhanced Intracellular Uptake of Curcumin in Retinal Cells Using Self-Emulsifying Drug Delivery Systems (SNEDDS)Elide Zingale, Sebastiano Masuzzo, Tatu Lajunen, et al.
Pharmaceutical Research|October 19, 2013
Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamineLauri Peura, Kalle Malmioja, Kristiina Huttunen, et al.
Bioorganic Chemistry|May 2, 2021
Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocationJussi Kärkkäinen, Tuomo Laitinen, Magdalena Markowicz-Piasecka, et al.
Journal of Medicinal Chemistry|February 3, 2006
Evaluation of hydroxyimine as cytochrome P450-selective prodrug structureHanna Kumpulainen, Niina Mähönen, Marja-Leena Laitinen, et al.
Pharmaceutical Research|March 21, 2007
Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionalityKristiina M Huttunen, Niina Mähönen, Jukka Leppänen, et al.
International Journal of Pharmaceutics|April 19, 2018
Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptakeJussi Kärkkäinen, Mikko Gynther, Tarja Kokkola, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 6, 2025
Synthesis, in vitro characterization and biopharmaceutical evaluation of a novel phosphate prodrug of sorafenibSimon Hoang Dinh, Christian Ding Fisker, Juulia Järvinen, et al.
Pageof 9